Traditional, complementary and alternative medicine activities
NORGESNAPRAPATENE AS
Revenue 2024
NOK 2.6m
Operating profit
NOK 172,000
Equity
NOK 722,000
Incorporated
2023
Share capital
NOK 30,000
Key figures · 2024
Current ratio
3.39
Equity ratio
73.9%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 6.7% | |
| Net margin (%%) | 5.3% | |
| Return on assets (%%) | 17.6% | |
| Likviditet | ||
| Current ratio | 3.39 | |
| Working capital | 612k | |
| Soliditet | ||
| Equity ratio (%%) | 73.9% | |
| Debt-to-equity ratio | 0.35 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.